Métastases hypophysaires : quand l’évoquer ? Étude rétrospective des patients opérés d’une métastase hypophysaire à l’hôpital Foch, Suresnes
Laure Cazabat(Hôpital Foch), S. Gaillard(Hôpital Foch), Sorin Aldéa, Chiara Villa(Centre National de la Recherche Scientifique), A. Boulin(Fondation de Rothschild), Salima Yamina Derdour(Hôpital Foch), Michèle Bernier(Hôpital Foch), Bertrand Baussart(Centre National de la Recherche Scientifique)
Cited by 0
Related Papers
Clinical Characteristics and Therapeutic Responses in Patients with Germ-Line<i>AIP</i>Mutations and Pituitary Adenomas: An International Collaborative Study
|The Journal of Clinical Endocrinology & Metabolism|2010|374
From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal
|Endocrine Related Cancer|2017|357
Gigantism and Acromegaly Due to Xq26 Microduplications and <i>GPR101</i> Mutation
|New England Journal of Medicine|2014|340
Pangenomic Classification of Pituitary Neuroendocrine Tumors
|Cancer Cell|2019|335
The 2016 World Health Organization classification of tumours of the central nervous system
|La Presse Médicale|2018|319